Skip to content

    Recently Viewed

      Listening...

      Home / Media Center / Press releases / Financial /
      Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

      Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

      Share Article
      share to

      NEW BRUNSWICK, N.J., Sept. 20, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, to review third-quarter results. Dominic Caruso, Executive Vice President, Chief Financial Officer, Joaquin Duato, Executive Vice President, Worldwide Chairman, Pharmaceuticals, Dr. William Hait, MD. PhD, Global Head Janssen Research & Development, LLC, and Joseph J. Wolk, Vice President, Investor Relations, will host the call.

      Investors and other interested parties may access the conference call in the following ways:

      • The webcast is accessible at Johnson & Johnson’s website: www.investor.jnj.com. A webcast and podcast replay will be available approximately one hour after the conference call concludes.
      • By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
      • A replay of the conference call will be available until approximately 12:00 a.m. on October 25, 2016. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13645877.
      • Presentation materials will be available on www.investor.jnj.com.
      • The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.

      About Johnson & Johnson

      Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,500 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

      Logo - http://photos.prnewswire.com/prnh/20160831/403394LOGO

      SOURCE Johnson & Johnson

      Press - Ernie Knewitz, (732) 524-6623 / (917) 697-2318 (M); Amy Jo Meyer, (732) 524-6678 / (908) 616-6250 (M) | Investors - Joseph J. Wolk, (732) 524-1142; Jason Valmore, (732) 524-3709

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.